Real-Time Scintigraphic Assessment of Intravenous Radium-223 Administration for Quality Control

Radium-223 ((223)Ra) dichloride is an approved intravenous radiotherapy for patients with osseous metastases from castration-resistant prostate cancer (CRPC). In addition to the therapeutic alpha radiation, there is additional (223)Ra radiation generated which produces photons that can be imaged wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Chadwick L., Monk, J. Paul, Murrey, Douglas A., Hall, Nathan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348603/
https://www.ncbi.nlm.nih.gov/pubmed/25789312
http://dx.doi.org/10.1155/2015/324708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348603/
https://www.ncbi.nlm.nih.gov/pubmed/25789312
http://dx.doi.org/10.1155/2015/324708

Ejemplares similares